234 556例外科主动脉瓣置换术患者手术量与结局的关联
基于胸外科医师学会成人心脏手术数据库2013年1月至2018年6月的234 556例患者,分析孤立或联合冠状动脉旁路移植术的外科主动脉瓣置换术年手术量与手术死亡率及复合主要并发症或死亡率的关系。结果显示手术结局与机构手术量呈负相关,但既往结局比既往手术量更能预测未来结局。
要点
- 年手术量最低组(1-25例)较最高组(>100例)调整后手术死亡风险升高,孤立SAVR的AOR为2.24(95%CI 1.91-2.64)。
- 年手术量最低组较最高组调整后复合主要并发症或死亡风险升高,孤立SAVR的AOR为1.53(95%CI 1.39-1.69)。
- 既往结局比既往手术量更能解释医院未来手术结局,许多低手术量医院也观察到良好结局。
核心结论
- 伴或不伴冠状动脉旁路移植术的外科主动脉瓣置换术手术结局与机构手术量呈负相关,但既往结局比既往手术量更能预测未来结局。
- 鉴于许多低手术量医院也观察到良好结局,手术结局可能比手术量更适合作为质量指标。
研究设计与样本
- 回顾性分析胸外科医师学会成人心脏手术数据库2013年1月至2018年6月234 556例患者,其中孤立SAVR 144 177例,SAVR联合冠状动脉旁路移植术90 379例。
- 按年化SAVR手术量分为4组:1-25例、26-50例、51-100例和>100例。
- 采用随机效应模型评估历史(2013-2015年)SAVR手术量或风险调整结局是否能解释未来(2016-2018年)风险调整结局。
主要发现
- 各中心年化SAVR手术量中位数为35例(四分位距22-59),其中孤立主动脉瓣置换20例,主动脉瓣置换联合冠状动脉旁路移植术13例。
- 在孤立SAVR病例中,最高手术量组(第4组)的平均手术死亡率和复合并发症或死亡率分别为1.5%和9.7%,手术量逐渐降低的组别中这些比率显著更高(趋势P<.001)。
- 调整后,较低手术量中心相比最高手术量机构的手术死亡风险升高:第1组与第4组(参照)比较,孤立SAVR的调整比值比(AOR)为2.24(95%CI 1.91-2.64),SAVR联合冠状动脉旁路移植术的AOR为1.96(95%CI 1.67-2.30)。
- 调整后,较低手术量中心相比最高手术量机构的复合主要并发症或死亡风险升高:孤立SAVR的AOR为1.53(95%CI 1.39-1.69),SAVR联合冠状动脉旁路移植术的AOR为1.46(95%CI 1.32-1.61)。
- 各手术量类别内医院间结局存在substantial变异,既往结局比既往手术量能解释更大比例的医院手术结局。
临床怎么用
- 原文结论指出手术结局可能比手术量更适合作为质量指标,但未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between institutional volume and operative mortality after surgical aortic valve replacement (SAVR) remains unclear. METHODS: From January 2013 to June 2018, 234 556 patients underwent isolated SAVR (n = 144 177) or SAVR with coronary artery bypass grafting (CABG) (n = 90 379) within the Society of Thoracic Surgeons Adult Cardiac Surgery Database. The association between annualized SAVR volume (group 1 [1-25 SAVRs], group 2 [26-50 SAVRs], group 3 [51-100 SAVRs], and group 4 [>100 SAVRs]) and operative mortality and composite major morbidity or mortality was assessed. Random effects models were used to evaluate whether historical (2013-2015) SAVR volume or risk-adjusted outcomes explained future (2016-2018) risk-adjusted outcomes. RESULTS: The annualized median number of SAVRs per site was 35 (interquartile range, 22-59; isolated aortic valve replacement [AVR], 20; AVR with CABG, 13). Among isolated SAVR cases, the mean operative mortality and composite morbidity or mortality were 1.5% and 9.7%, respectively, at the highest-volume sites (group 4), with significantly higher rates among progressively lower-volume groups (P trend < .001). After adjustment, lower-volume centers had increased odds of operative mortality (group 1 vs group 4 [reference]: adjusted odds ratio [AOR] for SAVR, 2.24 [95% CI, 1.91-2.64]; AOR for SAVR with CABG, 1.96 [95% CI, 1.67-2.30]) and major morbidity or mortality (AOR for SAVR, 1.53 [95% CI, 1.39-1.69]; AOR for SAVR with CABG, 1.46 [95% CI, 1.32-1.61]) compared with the highest-volume institutions. Substantial variation in outcomes was observed across hospitals within each volume category, and prior outcomes explained a greater proportion of hospital operative outcomes than did prior volume. CONCLUSIONS: Operative outcomes after SAVR with or without CABG is inversely associated with institutional procedure volumes; however, prior outcomes are more predictive of future outcomes than is prior volume. Given the excellent outcomes observed at many lower-volume hospitals, procedural outcomes may be preferable to procedural volumes as a quality metric.
引用
- Thourani VH, Brennan JM, Edelman JJ, et al. Association of Volume and Outcomes in 234 556 Patients Undergoing Surgical Aortic Valve Replacement. Ann Thorac Surg. 2021. PMID: 34785247. doi:10.1016/j.athoracsur.2021.06.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。